InsiderClue
← All stocks

AbCellera Biologics Inc.

ABCL Net buying
CIK 0001703057 #1583 in the set updated 17 Sep 2026
Bought (12 mo)
$2.68M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$2.68M
+$2.68M against sales at will

By person

5 insiders · 10 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Hayden Michael R
Director
$1.05M (2)
—
+$1.05M
1,373,397
0.4479%
$14.61M
+3.8%
Thermopylae Holdings Ltd. entity
10% owner
$711.00K (2)
—
+$711.00K
56,134,097
18.31%
$597.27M
+0.1%
Booth Andrew
Chief Financial Officer
$529.60K (2)
—
+$529.60K
482,800
0.1575%
$5.14M
+215.6%
Montalbano John S.
Director
$384.16K (3)
—
+$384.16K
251,000
0.0819%
$2.67M
+191.9%
Hansen Carl L. G.
Chief Executive Officer
—
—
—
898,000
0.2929%
$9.55M
+14.3%

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
Hayden Michael R
24 Aug 2026
Director
Buy indirect
53,613
$10.64
$570.44K
Montalbano John S.
18 Aug 2026
Director
Buy
10,000
$11.03
$110.30K
Booth Andrew
14 Aug 2026
Chief Financial Officer
Buy
37,200
$10.32
$383.90K
Hayden Michael R
12 Aug 2026
Director
Buy indirect
46,387
$10.37
$481.03K
Montalbano John S.
14 May 2026
Director
Buy
20,000
$4.77
$95.40K
Booth Andrew
27 Feb 2026
Chief Financial Officer
Buy
42,600
$3.42
$145.69K
Thermopylae Holdings Ltd.
27 Feb 2026
10% owner
Buy
38,000
$3.44
$130.72K
Thermopylae Holdings Ltd.
26 Feb 2026
10% owner
Buy
177,457
$3.27
$580.28K
Montalbano John S.
26 Nov 2025
Director
Buy
50,000
$3.57
$178.46K
Show all 10 transactions →

What was left out

Form 4 filings counted 22
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 525,000
History held since 17 Dec 2020